03/28/2025
4:36 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:18 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:20 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:24 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
4:29 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
5:19 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
5:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
3:27 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:29 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
03/10/2025
3:52 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for NAMS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors with MarketBeat's FREE daily newsletter. |
03/06/2025
4:32 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
5:10 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:54 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:06 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
02/26/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
4:24 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:42 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025
4:00 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:25 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:16 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
4:09 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025
3:52 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Somaiya Mayur Ian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
3:26 PM | NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:27 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
4:58 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:03 PM | Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:08 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
5:09 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
4:57 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:21 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:08 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:10 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:12 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:29 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/06/2025
4:57 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:48 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:51 PM | JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump Treasure April 19 (Ad) Thanks to President Trump…
A $900 investment across5 specific cryptos…
Could gain 12,000% so quickly that, just 12 months later… If I’m right about this (like I was before) a modest $900 investment… |
01/06/2025
4:53 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:54 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:56 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
3:25 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:35 PM | BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/17/2024
4:05 PM | Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:00 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/17/2024
9:28 AM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
12/16/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
7:28 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
5:33 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
12/12/2024
3:15 PM | Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:57 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-3MEF | |
12/10/2024
3:48 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
12/10/2024
6:24 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2024
6:07 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:29 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
11/14/2024
4:46 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/06/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024
7:02 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 20-F/A | |
10/18/2024
3:51 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
4:01 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:23 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:12 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
4:22 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:20 PM | AMGEN INC (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13G/A | |
08/22/2024
3:30 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
08/09/2024
4:21 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
08/09/2024
4:23 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:24 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form POS AM | |
08/07/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
7:30 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:30 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/19/2024
3:30 PM | Joustra Wouter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/19/2024
3:31 PM | McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
7:10 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2024
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
07/03/2024
3:34 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/03/2024
3:31 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/24/2024
7:30 AM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
7:12 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
3:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:18 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form ARS | |
Elon Set to Shock the World by May 1st ? (Ad) Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever…
Yes, even bigger than Tesla or SpaceX. Click here now because after May 1st, it could be too late. |
05/09/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:21 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
04/17/2024
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
Buy NAMS Stock Free NAMS Stock Alerts